With the FDA approval of BrainsWay back in August 2018, the company has seen significant growth ever since then. Some statistics reveal that the company had shipped 57 OCD coils to new clinics or upgraded its existing customers. At the end of 2018, there are 383 Deep TMS systems in the United States representing a 47% increase in machines and revenue dating back to last year.
